17.04.2019 Views

March 2019 digital v1

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

esearch snippets<br />

Fibrinogen induces spine<br />

elimination in Alzheimer’s<br />

Mario Merlini et al unveiled<br />

the role of the blood-clotting<br />

protein fibrinogen in blood in<br />

causing the characteristic cognitive<br />

decline of Alzheimer’s disease.<br />

Cerebrovascular alterations are a<br />

key feature of Alzheimer’s disease<br />

(AD) pathogenesis. The researchers<br />

used state-of-the-art imaging<br />

technology to produce the first<br />

three-dimensional volume images<br />

of Alzheimer’s disease. The images<br />

of the brains of patients with<br />

Alzheimer’s disease and mouse<br />

models were studied. The bloodprotein<br />

fibrinogen was seen to leak<br />

from the blood into the brain, where<br />

it activated the brain’s immune<br />

cells triggering them to destroy<br />

neuronal synapses. Fibrinogen then<br />

induces spine elimination leading<br />

to cognitive deficits mediated by<br />

CD11b-CD18 microglia activation.<br />

Fibrinogen-induced spine elimination<br />

was prevented by inhibiting<br />

reactive oxygen species (ROS)<br />

generation or by genetic elimination<br />

of CD11b. In the mouse models,<br />

this genetic elimination showed<br />

to reduce neuroinflammation,<br />

synaptic deficits and cognitive<br />

decline. The research thus unveils<br />

that fibrinogen-induced spine<br />

elimination and cognitive decline<br />

via CD11b leads to cerebrovascular<br />

damage with immune-mediated<br />

neurodegeneration and may have<br />

important implications in AD and<br />

related conditions.<br />

Source: Neuron Feb 5,t <strong>2019</strong> DOI: https://doi.<br />

org/10.1016/j.neuron.<strong>2019</strong>.01.014<br />

Ovarian cyst surgery<br />

often unnecessary<br />

Wouter Froyman et al shows<br />

evidence promoting a watchful<br />

waiting approach towards non-cancerous<br />

ovarian cyst. The researchers performed<br />

a two-year study involving 1919 women<br />

from 10 different countries, including<br />

the UK, Belgium, Sweden and Italy, who<br />

were diagnosed with non-cancerous<br />

ovarian cysts. The average age of the<br />

women in the study was 48, and the<br />

average size of the cyst was 4cm. Out of<br />

the 1919 women in the trial, 20 percent<br />

had cysts that disappeared of their<br />

own accord, and 16 percent underwent<br />

surgery. Overall, in 80 percent of cases<br />

either the cyst resolved or did not need<br />

intervention. Only 12 women were<br />

subsequently diagnosed with ovarian<br />

cancer, making the risk of cancer 0.4<br />

percent. The rate of other complications,<br />

such as ovarian twisting or cyst rupture<br />

was 0.4 percent and 0.2 percent<br />

respectively. The researchers suggest<br />

that the risk of malignancy and acute<br />

complications is low if adnexal masses<br />

with benign ultrasound morphology are<br />

managed conservatively, invasive surgical<br />

procedures can be avoided.<br />

Source: The Lancet Oncology February 05, <strong>2019</strong><br />

https://doi.org/10.1016/S1470-2045(18)30837-4<br />

Oral delivery of insulin<br />

via ingestible capsule<br />

A<br />

bramson et al. developed an<br />

ingestible drug delivery vehicle that<br />

can be used for oral administration<br />

of insulin. The capsule is designed<br />

to be able to self-reorient from any<br />

starting position so as to attach to<br />

the gastric wall. This ingestible selforienting<br />

millimeter-scale applicator<br />

(SOMA) autonomously positions itself<br />

with the gastrointestinal tissue. Within<br />

the capsule, a needle is attached to a<br />

compressed spring that is held in place<br />

by a disk made of sugar which gets<br />

dissolved on reaching the stomach.<br />

It then deploys its needles fabricated<br />

from active pharmaceutical ingredients<br />

directly through the gastric mucosa while<br />

avoiding perforation and delivers the<br />

active pharmaceutical ingredient. The<br />

approach successfully provided active<br />

insulin delivery in pigs and rat models.<br />

56 / FUTURE MEDICINE / <strong>March</strong> <strong>2019</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!